Ipca Laboratories Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 25	Mar ' 24	Mar ' 23	Mar ' 22	Mar ' 21

Sources of funds

Owner's fund

Equity share capital

25.37

25.37

25.37

25.37

25.37

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

6,866.25

6,323.34

5,851.93

5,497.97

4,727.35

Loan funds

Secured loans

871.73

1,132.91

1,422.61

761.01

223.20

Unsecured loans

-

-

-

-

-

Total

7,763.35

7,481.62

7,299.91

6,284.35

4,975.92

Uses of funds

Fixed assets

Gross block

4,311.48

4,086.38

3,817.97

3,210.57

2,822.88

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

1,774.77

1,562.82

1,339.31

1,125.79

954.28

Net block

2,536.71

2,523.56

2,478.66

2,084.78

1,868.60

Capital work-in-progress

489.91

175.34

123.02

289.04

182.00

Investments

2,693.26

2,654.16

1,056.73

1,447.52

867.84

Net current assets

Current assets, loans & advances

3,351.04

3,306.21

4,788.56

3,645.52

3,091.69

Less : current liabilities & provisions

1,307.57

1,177.65

1,147.06

1,182.51

1,034.21

Total net current assets

2,043.47

2,128.56

3,641.50

2,463.01

2,057.48

Miscellaneous expenses not written

-

-

-

-

-

Total

7,763.35

7,481.62

7,299.91

6,284.35

4,975.92

Notes:

Book value of unquoted investments

629.00

18.60

25.41

25.19

-

Market value of quoted investments

3,440.05

410.60

323.32

719.31

393.83

Contingent liabilities

490.63

308.45

2,161.85

287.71

382.20

Number of equity sharesoutstanding (Lacs)

2537.04

2537.04

2537.04

2537.04

1268.52